VireturnRevenue
199.1B USDAnnual · FY 2025ELV
Elevance Health, Inc.
Net income
5.7B USDAnnual · FY 2025Total assets
121.5B USDAnnual · FY 2025Equity
43.9B USDAnnual · FY 2025Revenue growth
12.5%Annual · FY 2025Net income growth
-5.3%Annual · FY 2025ELV · Chart
Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.
Reported financial information
Revenue
USD
199.1B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 138.6B USD |
| FY 2022 | 156.6B USD |
| FY 2023 | 171.3B USD |
| FY 2024 | 177B USD |
| FY 2025 | 199.1B USD |
Net income
USD
5.7B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 6.2B USD |
| FY 2022 | 5.9B USD |
| FY 2023 | 6B USD |
| FY 2024 | 6B USD |
| FY 2025 | 5.7B USD |
Total assets
USD
121.5B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 97.5B USD |
| FY 2022 | 102.8B USD |
| FY 2023 | 108.9B USD |
| FY 2024 | 116.9B USD |
| FY 2025 | 121.5B USD |
Equity
USD
43.9B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 36.1B USD |
| FY 2022 | 36.3B USD |
| FY 2023 | 39.4B USD |
| FY 2024 | 41.3B USD |
| FY 2025 | 43.9B USD |
Revenue growth
%
12.5%
Period data
| Period | Value |
|---|---|
| FY 2021 | 13.8% |
| FY 2022 | 13% |
| FY 2023 | 9.4% |
| FY 2024 | 3.3% |
| FY 2025 | 12.5% |
Net income growth
%
-5.3%
Period data
| Period | Value |
|---|---|
| FY 2021 | 34.7% |
| FY 2022 | -4.3% |
| FY 2023 | 1.6% |
| FY 2024 | -0.1% |
| FY 2025 | -5.3% |
Return on assets
%
4.8%
Period data
| Period | Value |
|---|---|
| FY 2021 | 6.7% |
| FY 2022 | 5.9% |
| FY 2023 | 5.7% |
| FY 2024 | 5.3% |
| FY 2025 | 4.8% |